Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19687327 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
Conditions: Malnutrition;   Pancreatic Cancer
Interventions: Biological: proteolytic enzymes;   Drug: gemcitabine hydrochloride;   Procedure: Gonzalez regimen

Indicates status has not been verified in more than two years